Names | |
---|---|
IUPAC name
2-(4-Hydroxyphenyl)ethyl β-D-glucopyranoside
| |
Systematic IUPAC name
(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol | |
Other names
Salidroside
Rhodioloside Tyrosol glucoside | |
Identifiers | |
3D model (
JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.224.258 |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C14H20O7 | |
Molar mass | 300.307 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Salidroside (rhodioloside) is a glucoside of tyrosol found in the plant Rhodiola rosea. [1] It has been studied, along with rosavin, as one of the potential compounds responsible for the putative antidepressant and anxiolytic actions of this plant. [2] [3] Salidroside may be more active than rosavin, [4] even though many commercially marketed Rhodiola rosea extracts are standardized for rosavin content rather than salidroside.
Salidroside was shown to improve glucose homeostasis and alleviate diabetic retinopathy in obese mice. [5] [6] The antioxidant, anti-inflammatory and neuroprotective effects of salidroside have also been reported. [7] [8] [9]
The salidroside biosynthetic pathway in Rhodiola rosea was described in 2018. [10] Rhodiola contains a pyridoxal phosphate-dependent 4-hydroxyphenylacetaldehyde (4-HPAA) synthase that converts tyrosine to 4-HPAA, which is further reduced to tyrosol by 4-HPAA reductase. Rhodiola contains a regio-selective tyrosol:UDP-glucose 8-O-glucosyltransferase that glycosylates tyrosol to produce salidroside.
Names | |
---|---|
IUPAC name
2-(4-Hydroxyphenyl)ethyl β-D-glucopyranoside
| |
Systematic IUPAC name
(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol | |
Other names
Salidroside
Rhodioloside Tyrosol glucoside | |
Identifiers | |
3D model (
JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.224.258 |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C14H20O7 | |
Molar mass | 300.307 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Salidroside (rhodioloside) is a glucoside of tyrosol found in the plant Rhodiola rosea. [1] It has been studied, along with rosavin, as one of the potential compounds responsible for the putative antidepressant and anxiolytic actions of this plant. [2] [3] Salidroside may be more active than rosavin, [4] even though many commercially marketed Rhodiola rosea extracts are standardized for rosavin content rather than salidroside.
Salidroside was shown to improve glucose homeostasis and alleviate diabetic retinopathy in obese mice. [5] [6] The antioxidant, anti-inflammatory and neuroprotective effects of salidroside have also been reported. [7] [8] [9]
The salidroside biosynthetic pathway in Rhodiola rosea was described in 2018. [10] Rhodiola contains a pyridoxal phosphate-dependent 4-hydroxyphenylacetaldehyde (4-HPAA) synthase that converts tyrosine to 4-HPAA, which is further reduced to tyrosol by 4-HPAA reductase. Rhodiola contains a regio-selective tyrosol:UDP-glucose 8-O-glucosyltransferase that glycosylates tyrosol to produce salidroside.